Is Dyadic International Inc (DYAI) overvalued? · rev $3.5M
Dyadic International Inc (DYAI) is a biotechnology company listed on US.
This page asks whether Dyadic International Inc (DYAI) looks expensive on cached numbers — not a short thesis.
Latest reported DYAI revenue for 2024-12-31 was $3.5M. Net income was -$5.8M. Revenue was up 20.6% from 2023-12-31 to 2024-12-31. DYAI currently screens at market cap $25.9M.
DYAI currently screens at market cap $25.9M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next DYAI 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the DYAI stock page for the full model, not this heading.
Not investment advice.